Novo Integrated Sciences Revenue 2012-2024 | NVOS

Novo Integrated Sciences revenue from 2012 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Novo Integrated Sciences Annual Revenue
(Millions of US $)
2023 $13
2022 $12
2021 $9
2020 $8
2019 $9
2018 $9
2017 $8
2016 $
2016 $7
2015 $
2014 $
2013 $
2012 $
2012 $
2011 $
2011 $
Novo Integrated Sciences Quarterly Revenue
(Millions of US $)
2024-02-29 $3
2023-11-30 $4
2023-08-31 $3
2023-05-31 $3
2023-02-28 $3
2022-11-30 $3
2022-08-31 $-8
2022-05-31 $14
2022-02-28 $3
2021-11-30 $3
2021-08-31 $3
2021-05-31 $2
2021-02-28 $2
2020-11-30 $2
2020-08-31 $2
2020-05-31 $1
2020-02-29 $2
2019-11-30 $3
2019-08-31 $2
2019-05-31 $2
2019-02-28 $2
2018-11-30 $2
2018-08-31 $2
2018-05-31 $2
2018-02-28 $2
2017-11-30 $2
2017-08-31 $2
2017-05-31 $2
2017-03-31
2017-02-28 $2
2016-12-31
2016-11-30 $2
2016-09-30
2016-06-30
2016-05-31 $2
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-08-31
2012-06-30
2012-03-31
2012-02-29
2011-12-31
2011-11-30
2011-09-30
2011-08-31
2011-06-30
2011-05-31
2011-03-31
2011-02-28
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.016B $0.013B
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.760B 10.74
Quest Diagnostics (DGX) United States $15.222B 15.73
DaVita (DVA) United States $12.387B 15.39
Elanco Animal Health (ELAN) United States $9.009B 23.37
Encompass Health (EHC) United States $8.590B 21.99
Chemed (CHE) United States $8.161B 25.30
Option Care Health (OPCH) United States $4.954B 18.75
RadNet (RDNT) United States $4.322B 90.00
Amedisys (AMED) United States $2.999B 21.25
Astrana Health (ASTH) United States $2.241B 30.30
LifeStance Health (LFST) United States $2.003B 0.00
Addus HomeCare (ADUS) United States $1.927B 27.56
U.S Physical Therapy (USPH) United States $1.451B 38.82
Pennant (PNTG) United States $0.687B 36.27
Aveanna Healthcare Holdings (AVAH) United States $0.548B 0.00
Atai Life Sciences (ATAI) Germany $0.224B 0.00
Daxor (DXR) United States $0.042B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.025B 0.00
ATI Physical Therapy (ATIP) United States $0.019B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Ontrak (OTRK) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00